CG Oncology director James Mulay disposes of common shares worth $1.82 million

• CG Oncology director James Mulay exercised director stock options for 24,165 common shares at $26.63 on July 10, 2026.
• Mulay sold 24,165 common shares at $75.16 on the same day, cutting his direct stake to 0 shares.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CG Oncology Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-303188), on July 14, 2026, and is solely responsible for the information contained therein.